Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Oncology, Kailuan General Hospital, Tangshan, China.
Int J Cancer. 2019 Jun 15;144(12):2972-2984. doi: 10.1002/ijc.32051. Epub 2019 Jan 12.
To investigate the independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males, a prospective cohort study was conducted. A total of 109,798 males with baseline information on total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and non-HDL were prospectively observed from 2006 to 2015 for cancer incidence. Cox proportional hazards models and restricted cubic spline (RCS) analysis were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). During a 9-year follow-up, a total of 986 lung cancer cases were identified. Multivariable analyses showed that both males with low TC (HR = 1.27, 95%CI: 1.02-1.60) and males with high TC (HR = 1.30, 95%CI: 1.04-1.63) had an increased lung cancer risk, and the U-shaped association was also revealed in the RCS analysis (p = 0.013, p = 0.006). Furthermore, both low TG (HR = 1.24, 95%CI: 0.99-1.54) and high TG (HR = 1.27, 95%CI: 1.01-1.59) were associated with increased lung cancer risk, while low LDL-C (HR = 1.38, 95%CI: 1.11-1.72) was associated with increased lung cancer risk. When TC, TG and LDL-C were considered jointly, the number of abnormal indicators was linearly associated with an increased risk of lung cancer (p < 0.001), as subjects with three abnormal indicators had a twofold higher risk of developing lung cancer (HR = 2.02, 95%CI: 1.62-2.54). Notably, these associations were statistically significant among never smokers, never drinkers and overweight/obese males. These findings suggest that dyslipidemia may potentially be a modifiable risk factor that has key scientific and clinical significance for lung cancer prevention.
为了研究血脂和脂蛋白与中国男性肺癌风险的独立和联合关联,进行了一项前瞻性队列研究。从 2006 年到 2015 年,共观察了 109798 名基线总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和非高密度脂蛋白胆固醇信息的男性,以观察癌症的发病率。使用 Cox 比例风险模型和限制性立方样条(RCS)分析来估计危险比(HR)和 95%置信区间(CI)。在 9 年的随访期间,共发现了 986 例肺癌病例。多变量分析表明,TC 水平低的男性(HR = 1.27,95%CI:1.02-1.60)和 TC 水平高的男性(HR = 1.30,95%CI:1.04-1.63)患肺癌的风险增加,RCS 分析也显示了 U 形关联(p = 0.013,p = 0.006)。此外,低 TG(HR = 1.24,95%CI:0.99-1.54)和高 TG(HR = 1.27,95%CI:1.01-1.59)均与肺癌风险增加相关,而低 LDL-C(HR = 1.38,95%CI:1.11-1.72)与肺癌风险增加相关。当 TC、TG 和 LDL-C 一起考虑时,异常指标的数量与肺癌风险的增加呈线性相关(p < 0.001),因为有三个异常指标的受试者患肺癌的风险增加了两倍(HR = 2.02,95%CI:1.62-2.54)。值得注意的是,这些关联在从不吸烟者、不饮酒者和超重/肥胖男性中具有统计学意义。这些发现表明,血脂异常可能是一个潜在的可改变的危险因素,对肺癌的预防具有重要的科学和临床意义。